In this episode, we’re joined by Professor Kevin Harrington, one of the world’s leading experts in head and neck cancer, to break down what’s really changing in tongue cancer treatment, and what it means for patients today. We talk about the rise in younger patients without clear risk factors, why we still don’t fully understand why this is happening, and what that uncertainty means for the future. We also dive into immunotherapy: what it actually is, how it works, and why it’s starting to change outcomes in ways that simply weren’t possible before.
If you’ve been diagnosed with tongue cancer (or are supporting someone who has), you can find help here:
🌍 Website
🤝 Join support groups & mailing list: via the website
💌 Contact us: podcast@youngtonguesglobal.com
We’re building this with our community — and you can be part of it:
✨ Volunteer & share your experience
🎙️ Apply to appear on the podcast
🧠 Take part in research opportunities
We’re a small charity with a big mission — and we rely on community support to keep going.
👉 Find out more how to make a donation or fundraise for us here
📲 Follow & Connect
Instagram | Facebook | TikTok | Mailing List
","author_name":"Barbara Fountain"}